Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Long-Term Investments (2016 - 2018)

Pediatrix Medical (MD) has disclosed Long-Term Investments for 10 consecutive years, with $69.7 million as the latest value for Q4 2018.

  • On a quarterly basis, Long-Term Investments fell 13.61% to $69.7 million in Q4 2018 year-over-year; TTM through Dec 2018 was $69.7 million, a 13.61% decrease, with the full-year FY2018 number at $69.7 million, down 13.61% from a year prior.
  • Long-Term Investments was $69.7 million for Q4 2018 at Pediatrix Medical, down from $81.2 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $90.3 million in Q1 2018 to a low of $56.5 million in Q1 2014.
  • A 5-year average of $72.9 million and a median of $72.1 million in 2016 define the central range for Long-Term Investments.
  • Peak YoY movement for Long-Term Investments: skyrocketed 33.53% in 2016, then dropped 13.61% in 2018.
  • Pediatrix Medical's Long-Term Investments stood at $64.1 million in 2014, then fell by 1.24% to $63.3 million in 2015, then grew by 24.79% to $79.0 million in 2016, then rose by 2.16% to $80.7 million in 2017, then fell by 13.61% to $69.7 million in 2018.
  • Per Business Quant, the three most recent readings for MD's Long-Term Investments are $69.7 million (Q4 2018), $81.2 million (Q3 2018), and $90.2 million (Q2 2018).